Smythe MA - Search Results

1

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Smythe MA, et al. J Thromb Thrombolysis. 2016 Jan;41(1):165-86. doi: 10.1007/s11239-015-1315-2. J Thromb Thrombolysis. 2016. PMID: 26780745 Free PMC article. Review.

2

Delayed-onset heparin-induced thrombocytopenia.

Smythe MA, Stephens JL, Mattson JC. Smythe MA, et al. Ann Emerg Med. 2005 Apr;45(4):417-9. doi: 10.1016/j.annemergmed.2004.08.005. Ann Emerg Med. 2005. PMID: 15795722

3

Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors.

Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK. Spinler SA, et al. Among authors: smythe ma. Ann Pharmacother. 2005 Jun;39(6):1049-55. doi: 10.1345/aph.1E118. Epub 2005 Apr 26. Ann Pharmacother. 2005. PMID: 15855245 Review.

4

Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.

Spinler SA, Wittkowsky AK, Nutescu EA, Smythe MA. Spinler SA, et al. Among authors: smythe ma. Ann Pharmacother. 2005 Jul-Aug;39(7-8):1275-85. doi: 10.1345/aph.1E524. Epub 2005 Jun 14. Ann Pharmacother. 2005. PMID: 15956240 Review.

5

Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.

Smythe MA, Koerber JM, Forsyth LL, Priziola JL, Balasubramaniam M, Mattson JC. Smythe MA, et al. Pharmacotherapy. 2009 Sep;29(9):1073-81. doi: 10.1592/phco.29.9.1073. Pharmacotherapy. 2009. PMID: 19698012

6

Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.

Myzienski AE, Lutz MF, Smythe MA. Myzienski AE, et al. Among authors: smythe ma. Pharmacotherapy. 2010 Mar;30(3):324. doi: 10.1592/phco.30.3.324. Pharmacotherapy. 2010. PMID: 20180615 Review.

7

Changes in the USP heparin monograph and implications for clinicians.

Smythe MA, Nutescu EA, Wittkowsky AK. Smythe MA, et al. Pharmacotherapy. 2010 May;30(5):428-31. doi: 10.1592/phco.30.5.428. Pharmacotherapy. 2010. PMID: 20411994 No abstract available.

8

Drug-induced thrombocytopenia in critically ill patients.

Priziola JL, Smythe MA, Dager WE. Priziola JL, et al. Among authors: smythe ma. Crit Care Med. 2010 Jun;38(6 Suppl):S145-54. doi: 10.1097/CCM.0b013e3181de0b88. Crit Care Med. 2010. PMID: 20502168 Review.

9

Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.

Smythe MA, Mehta TP, Koerber JM, Forsyth LL, Sykes E, Corbets LR, Melendy SM, Parikh R. Smythe MA, et al. Am J Health Syst Pharm. 2012 Feb 1;69(3):241-8. doi: 10.2146/ajhp110313. Am J Health Syst Pharm. 2012. PMID: 22261947

10

Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost.

Smythe MA, Koerber JM, Mehta TP, Forsyth LL, Conger E, Corbets LR, Mattson JC. Smythe MA, et al. Thromb Haemost. 2012 Nov;108(5):992-8. doi: 10.1160/TH12-05-0289. Epub 2012 Sep 5. Thromb Haemost. 2012. PMID: 22955669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page